5 completed, 2 recruiting, 2 unknown, 1 not yet recruiting. 5 Phase 4, 2 Phase 1, 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Recruiting 2, Completed 1, Not yet recruiting 1, Unknown 1 |
| Phase 1 | 2 | Completed 1, Unknown 1 |
| Phase 3 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow clopidogrel 75 mg: new trials by email Literature Review of clopidogrel 75 mg trials Research Report on clopidogrel 75 mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Short-Term Dual Antiplatelet Therapy With Early Transi-tion to Low-dose Antiplatelet Monotherapy Using Ti-cagRelor in Chronic Coronary Artery Disease Ticagrelor 60 mg, clopidogrel 75 mg - Chronic Coronary Syndrome | Phase 4 | Not yet recruiting | University of Messina | 1000 | 2026-11-01 | 2026-09-15 |
| Multicenter Trial of Antithrombotic Strategies in Acute Coronary Syndrome With Coronary Artery Ectasia Aspirin 100 mg, Clopidogrel 75 mg, Rivaroxaban 15 mg - Coronary Artery Ectasia, Acute Coronary Syndromes (ACS) | Phase 4 | Recruiting | Instituto Nacional de Cardiologia Ignacio Chavez | 326 | 2026-02-11 | 2026-04-09 |
| Comparison of Dual Antiplatelet Therapy De-escalation by Dose Reduction Versus Switching in Patients Undergoing PCI: The Switching Antiplatelet-8 (SWAP-8) Study clopidogrel 75 mg, Prasugrel 5 mg - Coronary Artery Disease | Phase 4 | Recruiting | University of Florida | 78 | 2025-03-10 | 2026-05-12 |
| Effect of Tegoprazan on Pharmacodynamics of Clopidogrel in Healthy Subjects Clopidogrel 75 mg, Tegoprazan 25 mg, Esomeprazole 20mg - Healthy | Phase 1 | Unknown | HK inno.N Corporation | 48 | 2023-12-05 | 2023-12-11 |
| Optimal Dosage of Ticagrelor in Korean Patients With AMI Clopidogrel 75 mg, Ticagrelor 60mg, Ticagrelor 45 mg - Acute Myocardial Infarction, Ticagrelor | Phase 4 | Unknown | Dong-A University | 120 | 2022-01-01 | 2022-01-27 |
| Efficacy of Ticagrelor Plus Aspirin in Mild Non-cardioembolic Ischemic Stroke Ticagrelor 90mg, Clopidogrel 75 mg - Ischemic Stroke, Transient Ischemic Attack | Phase 3 | Completed | Mazandaran University of Medical Sciences | 90 | 2021-08-08 | 2023-10-19 |
| Effect of Tegoprazan on Pharmacodynamics of Clopidogrel in Healthy Male Participants Clopidogrel 75 mg, Tegoprazan 50 mg, Esomeprazole 20 mg - Healthy | Phase 1 | Completed | HK inno.N Corporation | 25 | 2019-01-21 | 2019-10-21 |
| Half Dose of Prasugrel and Ticagrelor in Acute Coronary Syndrome (HOPE-TAILOR) Clopidogrel 75 mg, Prasugrel 5 mg, Ticagrelor 45 mg - Acute Coronary Syndrome | Phase 3 | Completed | Dong-A University | 120 | 2016-09-01 | 2020-08-20 |
| Edoxaban in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy With Aspirin and Clopidogrel Edoxaban 60 mg, Edoxaban 30 mg, Clopidogrel 75 mg - Coronary Artery Disease | Phase 4 | Completed | University of Florida | 80 | 2016-03-01 | 2018-04-06 |
| Clopidogrel Pharmacogenomics Project clopidogrel 75 mg, Clopidogrel 150 mg - Disease Susceptibility | Phase 2 | Completed | University of North Carolina, Chapel Hill | 50 | 2010-03-01 | 2017-12-12 |
Acute Coronary Syndrome (2) · Coronary Artery Disease (2) · Coronary Aneurysm (1) · Disease Susceptibility (1) · Ischemic Attack, Transient (1) · Ischemic Stroke (1) · Recurrence (1) · ST Elevation Myocardial Infarction (1)
Dong-A University (2) · HK inno.N Corporation (2) · University of Florida (2) · Instituto Nacional de Cardiologia Ignacio Chavez (1) · Mazandaran University of Medical Sciences (1) · University of Messina (1) · University of North Carolina, Chapel Hill (1)
South Korea (4) · United States (3) · Iran (1) · Mexico (1)
Moo Hyun Kim, MD (2) · Athena Sharifi-Razavi (1) · Dominick J Angiolillo, MD, PhD (1) · In-Jin Jang (1) · Joseph Rossi, MD (1) · Seung Hwan Lee (1)